Stability of lyophilized sucrose formulations of an IgG1: subvisible particle formation

By Davis Janice M.  

Pharmaceutical Development and Technology, Vol. 18, Iss. 4, 2013-08 ,pp. : 883-896

Informa Healthcare

Access to resources Recommend Favorite

Effects of Arginine on Photostability and Thermal Stability of IgG1 Monoclonal Antibodies

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 8, 2009-12 ,pp. : 761-766

Bentham Science Publishers

Access to resources Recommend Favorite

In Vivo Fluorescence Imaging of IgG1 Aggregates After Subcutaneous and Intravenous Injection in Mice

By Filipe Vasco   Que Ivo   Carpenter John   Löwik Clemens   Jiskoot Wim  

Pharmaceutical Research, Vol. 31, Iss. 1, 2014-01 ,pp. : 216-227

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab: an IgG1 monoclonal antibody for the treatment of epidermal growth factor receptor-expressing tumours

By Humblet Yves  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1621-1633

Informa Healthcare

Access to resources Recommend Favorite

Population Pharmacokinetic Evaluation of a Fully Human IgG2 Monoclonal Antibody in Patients with Inflammatory Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 4, 2010-09 ,pp. : 229-237

Bentham Science Publishers

Access to resources Recommend Favorite